ANGIODYNAMICS INC (ANGO) Stock News

USA - Nasdaq - NASDAQ:ANGO - US03475V1017 - Common Stock

12.3 USD

-0.1 (-0.81%)

Last: 11/26/2025, 4:30:08 PM

12.3 USD

0 (0%)

After Hours: 11/26/2025, 4:30:08 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

ANGO Latest News, Press Relases and Analysis

All

Press Releases

5 days ago - By: Zacks Investment Research - Mentions: BSX ISRG MEDP

Reasons to Hold AngioDynamics Stock in Your Portfolio for Now

22 days ago - By: The Motley Fool - Mentions: SBH SOI MG NGS ...

Acuitas Dumps Entire Stake in SBH Valued at $2.7 Million

23 days ago - By: The Motley Fool - Mentions: MCHB SEI AOSL MG ...

Is Mechanics Bancorp Stock a Buy After Investment Firm Acuitas Initiated a Large Position in the Bank?

a month ago - By: AngioDynamics, Inc.

AngioDynamics to Participate in the UBS Global Healthcare Conference

a month ago - By: AngioDynamics, Inc.

AngioDynamics’ NanoKnife® System Named to TIME’s 2025 Best Inventions List

2 months ago - By: Benzinga

Earnings Scheduled For October 2, 2025

2 months ago - By: Benzinga

AngioDynamics Eyes Growth Despite Tariffs

3 months ago - By: Zacks Investment Research - Mentions: PEN

Why Is Penumbra (PEN) Up 5% Since Last Earnings Report?

2 months ago - By: Zacks Investment Research - Mentions: EW

AngioDynamics (ANGO) Reports Q1 Loss, Tops Revenue Estimates

2 months ago - By: AngioDynamics, Inc.

AngioDynamics Reports Fiscal Year 2026 First Quarter Financial Results; Med Tech Growth of 26.1% Drives Continued Momentum

2 months ago - By: AngioDynamics, Inc.

AngioDynamics to Report Fiscal 2026 First Quarter Results on October 2, 2025

3 months ago - By: Zacks Investment Research - Mentions: NTRB

Nutriband Inc. (NTRB) Reports Q2 Loss, Lags Revenue Estimates

3 months ago - By: Zacks Investment Research - Mentions: BSX WST MEDP

Reasons to Hold AngioDynamics Stock in Your Portfolio for Now

4 months ago - By: AngioDynamics, Inc.

AngioDynamics to Present at the Canaccord Genuity 45th Annual Growth Conference

4 months ago - By: AngioDynamics, Inc.

AngioDynamics Enrolls First Patient in AMBITION BTK Trial Advancing Treatment for Critical Limb Ischemia

4 months ago - By: AngioDynamics, Inc.

AngioDynamics Announces Publication of PRESERVE Study of NanoKnife® System for Prostate Tissue Ablation in European Urology

4 months ago - By: Yahoo Finance

Why AngioDynamics Stock Popped, Then Dropped Today

4 months ago - By: AngioDynamics, Inc.

AngioDynamics Reports Strong Fiscal Year 2025 Fourth Quarter and Full Year Financial Results; Continued Execution Driving Accelerated, Profitable Growth